|
SKAP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.567900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.776300E-04 |
| Normal-vs-Stage2 |
3.159900E-04 |
| Normal-vs-Stage3 |
6.035800E-03 |
| Normal-vs-Stage4 |
1.530410E-02 |
| Stage1-vs-Stage2 |
5.094100E-02 |
| Stage1-vs-Stage3 |
8.870000E-01 |
| Stage1-vs-Stage4 |
9.161600E-01 |
| Stage2-vs-Stage3 |
8.938500E-02 |
| Stage2-vs-Stage4 |
2.092400E-01 |
| Stage3-vs-Stage4 |
8.603000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.419600E-03 |
| Normal-vs-AfricanAmerican |
5.963600E-03 |
| Normal-vs-Asian |
1.222480E-02 |
| Caucasian-vs-AfricanAmerican |
4.022400E-01 |
| Caucasian-vs-Asian |
9.951800E-01 |
| AfricanAmerican-vs-Asian |
3.683800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.016020E-04 |
| Normal-vs-Female |
1.404260E-03 |
| Male-vs-Female |
1.235440E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.902600E-03 |
| Normal-vs-Age(41-60Yrs) |
8.20700000000452E-05 |
| Normal-vs-Age(61-80Yrs) |
7.980600E-03 |
| Normal-vs-Age(81-100Yrs) |
2.395200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.264240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.795000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.951800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.340800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.196600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.023000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.160600E-01 |
| Classical-VS-Follicular |
1.16820000339857E-08 |
| Classical-VS-Other |
4.587600E-02 |
| Classical-VS-Normal |
1.576440E-02 |
| Tall-VS-Follicular |
5.016900E-04 |
| Tall-VS-Other |
7.380500E-02 |
| Tall-VS-Normal |
1.730210E-01 |
| Follicular-VS-Other |
8.892200E-01 |
| Follicular-VS-Normal |
5.72170000268102E-09 |
| Other-VS-Normal |
9.125000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.805690E-04 |
| Normal-vs-N1 |
1.297310E-03 |
| N0-vs-N1 |
9.593200E-01 |
|
|
